[Circulating anticoagulants during hemophilia].
D000906:Antibodies / Q000302:isolation & purification; D000917:Antibody Formation; D000925:Anticoagulants / Q000097:blood*; D001803:Blood Transfusion; D005078:Exchange Transfusion, Whole Blood; D005164:Factor IX / Q000037:antagonists & inhibitors; D005169:Factor VIII / Q000032:analysis / Q000037:antagonists & inhibitors; D006467:Hemophilia A / Q000503:physiopathology* / Q000628:therapy; D002836:Hemophilia B / Q000097:blood*; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D011487:Protein Conformation
D000906:Antibodies; D000925:Anticoagulants; D007074:Immunoglobulin G; D005169:Factor VIII; D005164:Factor IX
Les anticoagulants circulants au cours de l'hémophilie.